Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
复制标题
DOI：
10.15585/mmwr.mm7148e1
复制
发表时间：
2022-12-02
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
""